These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

494 related items for PubMed ID: 30801960

  • 1. MicroRNA-383 inhibits doxorubicin resistance in hepatocellular carcinoma by targeting eukaryotic translation initiation factor 5A2.
    Tu C, Chen W, Wang S, Tan W, Guo J, Shao C, Wang W.
    J Cell Mol Med; 2019 Nov; 23(11):7190-7199. PubMed ID: 30801960
    [Abstract] [Full Text] [Related]

  • 2. Circ_0003998 enhances doxorubicin resistance in hepatocellular carcinoma by regulating miR-218-5p/EIF5A2 pathway.
    Li X, He J, Ren X, Zhao H, Zhao H.
    Diagn Pathol; 2020 Dec 11; 15(1):141. PubMed ID: 33308276
    [Abstract] [Full Text] [Related]

  • 3. Knockdown of eukaryotic translation initiation factor 5A2 enhances the therapeutic efficiency of doxorubicin in hepatocellular carcinoma cells by triggering lethal autophagy.
    Tang Y, Chen K, Luan X, Zhang J, Liu R, Zheng X, Xie S, Ke H, Zhang X, Chen W.
    Int J Oncol; 2020 Dec 11; 57(6):1368-1380. PubMed ID: 33174013
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Long noncoding RNA LEF1-AS1 acts as a microRNA-10a-5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway.
    Gao J, Dai C, Yu X, Yin XB, Zhou F.
    J Cell Biochem; 2021 Jan 11; 122(1):86-99. PubMed ID: 32786108
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. MiR-26 enhances chemosensitivity and promotes apoptosis of hepatocellular carcinoma cells through inhibiting autophagy.
    Jin F, Wang Y, Li M, Zhu Y, Liang H, Wang C, Wang F, Zhang CY, Zen K, Li L.
    Cell Death Dis; 2017 Jan 12; 8(1):e2540. PubMed ID: 28079894
    [Abstract] [Full Text] [Related]

  • 10. MicroRNA31-NDRG3 regulation axes are essential for hepatocellular carcinoma survival and drug resistance.
    Du Z, Niu S, Xu X, Xu Q.
    Cancer Biomark; 2017 Jan 12; 19(2):221-230. PubMed ID: 28269758
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Eukaryotic translation initiation factor 5A2 regulates the migration and invasion of hepatocellular carcinoma cells via pathways involving reactive oxygen species.
    Liu RR, Lv YS, Tang YX, Wang YF, Chen XL, Zheng XX, Xie SZ, Cai Y, Yu J, Zhang XN.
    Oncotarget; 2016 Apr 26; 7(17):24348-60. PubMed ID: 27028999
    [Abstract] [Full Text] [Related]

  • 13. N1-guanyl-1,7-diaminoheptane (GC7) enhances the therapeutic efficacy of doxorubicin by inhibiting activation of eukaryotic translation initiation factor 5A2 (eIF5A2) and preventing the epithelial-mesenchymal transition in hepatocellular carcinoma cells.
    Lou B, Fan J, Wang K, Chen W, Zhou X, Zhang J, Lin S, Lv F, Chen Y.
    Exp Cell Res; 2013 Oct 15; 319(17):2708-17. PubMed ID: 23958463
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. MicroRNA-520c-3p Modulates Doxorubicin-Chemosensitivity in HepG2 Cells.
    Ragheb MA, Soliman MH, Elzayat EM, Mohamed MS, El-Ekiaby N, Abdelaziz AI, Abdel-Wahab AA.
    Anticancer Agents Med Chem; 2021 Oct 15; 21(2):237-245. PubMed ID: 32357822
    [Abstract] [Full Text] [Related]

  • 18. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
    Du H, Xu Q, Xiao S, Wu Z, Gong J, Liu C, Ren G, Wu H.
    Life Sci; 2019 May 01; 224():1-11. PubMed ID: 30876939
    [Abstract] [Full Text] [Related]

  • 19. Hsa_circ_0003998 promotes epithelial to mesenchymal transition of hepatocellular carcinoma by sponging miR-143-3p and PCBP1.
    Song LN, Qiao GL, Yu J, Yang CM, Chen Y, Deng ZF, Song LH, Ma LJ, Yan HL.
    J Exp Clin Cancer Res; 2020 Jun 17; 39(1):114. PubMed ID: 32552766
    [Abstract] [Full Text] [Related]

  • 20. Long Noncoding RNA MALAT1 Contributes to Sorafenib Resistance by Targeting miR-140-5p/Aurora-A Signaling in Hepatocellular Carcinoma.
    Fan L, Huang X, Chen J, Zhang K, Gu YH, Sun J, Cui SY.
    Mol Cancer Ther; 2020 May 17; 19(5):1197-1209. PubMed ID: 32220970
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.